Andera Partners | WebDisclosure

Basculer en Français

9775	Companies
195634	Keywords
126623	Articles
104003	Press releases

Home
Companies
Andera Partners

BRIEF

published on 01/20/2026 at 07:40, 10 days 7 hours ago

Exciva obtient 51 millions d'euros pour faire progresser son programme clinique sur la maladie d'Alzheimer

Essais Cliniques Financement De Série B Partenaires D'Andera Exciva Agitation Liée À La Maladie D'Alzheimer
BRIEF

published on 01/20/2026 at 07:40, 10 days 7 hours ago

Exciva Secures €51 Million to Advance Alzheimer's Clinical Program

Series B Funding Clinical Trials Andera Partners Alzheimer's Agitation Exciva
PRESS RELEASE

published on 01/20/2026 at 07:35, 10 days 7 hours ago

Andera Partners’ Portfolio Company Exciva Secures €51 Million Series B to Advance Clinical Program for Alzheimer’s-Related Agitation
Andera Partners' portfolio company Exciva secures €51 million Series B funding for Alzheimer's-related agitation clinical program, led by Gimv and EQT Life Sciences

Series B Funding Alzheimer's Disease Clinical Program Andera Partners Exciva
BRIEF

published on 01/08/2026 at 13:40, 22 days 1 hour ago

Andera Partners codirige un tour de table de série A de 160 millions de dollars pour les thérapies contre l'obésité d'Alveus

Maladies Métaboliques Financement De Série A Thérapies Contre L'obésité Partenaires D'Andera Thérapeutiques Alveus
BRIEF

published on 01/08/2026 at 13:40, 22 days 1 hour ago

Andera Partners Co-Leads $160 Million Series A for Alveus' Obesity Therapies

Series A Funding Metabolic Diseases Andera Partners Obesity Therapies Alveus Therapeutics
PRESS RELEASE

published on 01/08/2026 at 13:35, 22 days 1 hour ago

Andera Partners co-leads $160 Million Series A round for Alveus to Advance Next-Generation Therapies for Obesity and Metabolic Diseases
Andera Partners co-leads $160 Million Series A round for Alveus to Advance Next-Generation Therapies for Obesity and Metabolic Diseases

Biotechnology Metabolic Diseases Andera Partners Obesity Series A
BRIEF

published on 01/07/2026 at 14:10, 23 days ago

Andera Partners Leads $67 Million Series A for Spiro Medical's Asthma Innovation

Series A Funding Andera Partners Neuromodulation Asthma Treatment Spiro Medical
BRIEF

published on 01/07/2026 at 14:10, 23 days ago

Andera Partners mène un tour de table de série A de 67 millions de dollars pour l'innovation dans le domaine de l'asthme de Spiro Medical.

Financement De Série A Neuromodulation Traitement De L'asthme Spiro Medical Partenaires D'Andera
PRESS RELEASE

published on 01/07/2026 at 14:05, 23 days 1 hour ago

Andera Partners Leads $67 Million Series A Financing in Spiro Medical to Develop a Neuromodulation System for Asthma
Andera Partners leads $67 million Series A financing in Spiro Medical to develop a Neuromodulation System for Asthma, aiming to revolutionize treatment. Key investors include Omega Funds and Sherpa Healthcare Partners

Series A Financing Andera Partners Asthma Treatment Spiro Medical Neuromodulation System
BRIEF

published on 10/22/2025 at 09:05, 3 months 8 days ago

Ipsen Acquires ImCheck Therapeutics to Strengthen Oncology Portfolio

Biotechnology Oncology Immunotherapy Mergers & Acquisitions AML

1 2 ... 7

Accesswire

Published on 01/30/2026 at 14:00, 1 hour 8 minutes ago

CCL to Hold Live Webcast to Discuss Fourth Quarter and Year End 2025 Results, Thursday, February 26, 2026, at 7:30 a.m. ET
Published on 01/30/2026 at 08:35, 6 hours 33 minutes ago

Alaska Energy Metals Announces Closing Of Life Offering of Units
Published on 01/30/2026 at 08:00, 7 hours 8 minutes ago

Troubadour Resources Intercepts Target Mineralization Near Surface during Phase 1 of the Multi-Phase Drill Program at Senneville Gold-Silver-Copper Property
Published on 01/30/2026 at 02:15, 12 hours 53 minutes ago

Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 15 hours 8 minutes ago

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies

View all ACCESSWIRE

EQS Group

Published on 01/30/2026 at 14:52, 16 minutes ago

Edison issues report on Henderson Far East Income (HFEL)
Published on 01/30/2026 at 14:11, 57 minutes ago

SBF AG expects stable to positive business development in a challenging environment for 2026
Published on 01/30/2026 at 13:30, 1 hour 37 minutes ago

North Peak Expands Wabash Gold Mineralization at Prospect Mountain, Nevada
Published on 01/30/2026 at 12:00, 3 hours 8 minutes ago

HSBC UK and Sage simplify tax reporting for small businesses ahead of Making Tax Digital
Published on 01/30/2026 at 11:54, 3 hours 14 minutes ago

EQS-Adhoc: YOC AG: PRELIMINARY FIGURES FOR THE 2025 FINANCIAL YEAR

Les Echos

Published on 01/30/2026 at 08:30, 6 hours 38 minutes ago

Claude Bernard lance Senior+, un assistant IA conçu pour améliorer la prise en charge des patients les plus âgés
Published on 01/30/2026 at 08:00, 7 hours 8 minutes ago

AMA: 4th Quarter & FY 2025 Revenues
Published on 01/30/2026 at 08:00, 7 hours 8 minutes ago

AMA : Chiffre d'affaires du 4ème trimestre et de l'année 2025
Published on 01/29/2026 at 18:30, 20 hours 38 minutes ago

ALPOU - Groupe POULAILLON chiffre d'affaires trimestriel T1 2025-2026 et Focus sur les activités
Published on 01/29/2026 at 18:07, 21 hours 1 minute ago

CDA - Mise à disposition de l'URD 2025

View all LES ECHOS COMFI WIRE